tradingkey.logo
tradingkey.logo

Athira Pharma Inc

ATHA
6.750USD
0.0000.00%
Close 03/30, 16:00ETQuotes delayed by 15 min
26.62MMarket Cap
LossP/E TTM
You can find the annual or quarterly income statement of Athira Pharma Inc here for insights into the performance and operational efficiency of Athira Pharma Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
Operating expenses
-32.69%10.48M
-73.04%6.87M
-73.99%7.29M
-65.56%9.54M
-49.20%15.57M
-27.25%25.49M
-11.42%28.03M
-7.00%27.69M
33.65%30.64M
45.20%35.04M
34.24%31.64M
27.29%29.77M
22.10%22.93M
35.38%24.13M
41.67%23.57M
116.93%23.39M
106.83%18.78M
140.99%17.83M
--16.64M
--10.78M
--9.08M
--7.40M
R&D expenses
-28.37%6.71M
-84.24%2.83M
-83.47%3.66M
-79.74%4.30M
-60.43%9.37M
-34.12%17.92M
2.49%22.15M
-0.27%21.24M
55.42%23.68M
60.34%27.20M
46.02%21.61M
47.25%21.29M
20.75%15.24M
58.45%16.96M
23.11%14.80M
94.22%14.46M
143.26%12.62M
83.65%10.71M
--12.02M
--7.45M
--5.19M
--5.83M
Depreciation, depletion, and amortization
----
0.00%243.00K
0.41%243.00K
0.41%243.00K
-0.82%243.00K
-0.41%243.00K
-0.82%242.00K
2.54%242.00K
2.51%245.00K
5.63%244.00K
10.41%244.00K
53.25%236.00K
89.68%239.00K
87.80%231.00K
87.29%221.00K
37.50%154.00K
--126.00K
--123.00K
--118.00K
--112.00K
----
----
Operating profit
32.69%-10.48M
73.04%-6.87M
73.99%-7.29M
65.56%-9.54M
49.20%-15.57M
27.25%-25.49M
11.42%-28.03M
7.00%-27.69M
-33.65%-30.64M
-45.20%-35.04M
-34.24%-31.64M
-27.29%-29.77M
-22.10%-22.93M
-35.38%-24.13M
-41.67%-23.57M
-116.93%-23.39M
-106.83%-18.78M
-140.99%-17.83M
---16.64M
---10.78M
---9.08M
---7.40M
Net non-operating interest income (expenses)
Non-operating interest income
----
----
----
----
----
----
----
----
----
----
----
----
----
1233.78%987.00K
566.22%493.00K
108.33%175.00K
32.91%105.00K
111.43%74.00K
--74.00K
--84.00K
--79.00K
--35.00K
Non-operating interest expense
----
----
----
----
----
----
----
----
----
----
----
----
----
100.00%2.00K
--0.00
--2.00K
100.00%2.00K
--1.00K
--0.00
--0.00
--1.00K
--0.00
Special income (expenses)
---72.67M
----
----
----
-100.00%0.00
---4.13M
----
----
116.28%1.63M
----
----
----
---10.00M
----
----
----
--0.00
100.00%0.00
--0.00
--0.00
--0.00
---1.09M
Other non-operating income (expenses)
-54.71%255.00K
-70.11%263.00K
-72.20%325.00K
-70.89%393.00K
-67.44%563.00K
-57.53%880.00K
-42.78%1.17M
-30.77%1.35M
-38.07%1.73M
-29.98%2.07M
262.27%2.04M
-12.71%1.95M
19.52%2.79M
42.33%2.96M
-148.63%-1.26M
22.01%2.23M
79.83%2.34M
--2.08M
--2.59M
--1.83M
--1.30M
--0.00
Income before tax
-452.48%-82.89M
77.00%-6.61M
74.06%-6.97M
65.28%-9.14M
45.01%-15.00M
12.83%-28.74M
9.25%-26.86M
5.33%-26.34M
9.46%-27.29M
-63.31%-32.97M
-21.62%-29.60M
-32.60%-27.82M
-84.44%-30.14M
-28.81%-20.19M
-74.14%-24.34M
-136.63%-20.98M
-112.14%-16.34M
-85.36%-15.67M
---13.97M
---8.87M
---7.70M
---8.46M
Income after tax
-452.48%-82.89M
77.00%-6.61M
74.06%-6.97M
65.28%-9.14M
45.01%-15.00M
12.83%-28.74M
9.25%-26.86M
5.33%-26.34M
9.46%-27.29M
-63.31%-32.97M
-21.62%-29.60M
-32.60%-27.82M
-84.44%-30.14M
-28.81%-20.19M
-74.14%-24.34M
-136.63%-20.98M
-112.14%-16.34M
-85.36%-15.67M
---13.97M
---8.87M
---7.70M
---8.46M
Net income from continuous operations
-452.48%-82.89M
77.00%-6.61M
74.06%-6.97M
65.28%-9.14M
45.01%-15.00M
12.83%-28.74M
9.25%-26.86M
5.33%-26.34M
9.46%-27.29M
-63.31%-32.97M
-21.62%-29.60M
-32.60%-27.82M
-84.44%-30.14M
-28.81%-20.19M
-74.14%-24.34M
-136.63%-20.98M
-112.14%-16.34M
-85.36%-15.67M
---13.97M
---8.87M
---7.70M
---8.46M
Net income attributable to controlling interests
-452.48%-82.89M
77.00%-6.61M
74.06%-6.97M
65.28%-9.14M
45.01%-15.00M
12.83%-28.74M
9.25%-26.86M
5.33%-26.34M
9.46%-27.29M
-63.31%-32.97M
-21.62%-29.60M
-32.60%-27.82M
-84.44%-30.14M
-28.81%-20.19M
-74.14%-24.34M
-136.63%-20.98M
-112.14%-16.34M
-85.36%-15.67M
---13.97M
---8.87M
---7.70M
---8.46M
Net income attributable to common shareholders
-452.48%-82.89M
77.00%-6.61M
74.06%-6.97M
65.28%-9.14M
45.01%-15.00M
12.83%-28.74M
9.25%-26.86M
5.33%-26.34M
9.46%-27.29M
-63.31%-32.97M
-21.62%-29.60M
-32.60%-27.82M
-84.44%-30.14M
-28.81%-20.19M
-74.14%-24.34M
-136.63%-20.98M
-112.14%-16.34M
-85.36%-15.67M
---13.97M
---8.87M
---7.70M
---8.46M
Basic earnings per share
-3914.03%-15.56
-124.65%-1.68
-154.62%-1.78
65.93%-0.23
45.87%-0.39
13.87%-0.75
10.15%-0.70
6.31%-0.69
10.05%-0.72
-62.29%-0.87
-20.56%-0.78
-31.45%-0.73
-118.00%-0.80
-27.08%-0.53
-72.05%-0.65
-125.20%-0.56
-73.93%-0.37
-54.44%-0.42
---0.38
---0.25
---0.21
---0.27
Diluted earnings per share
-3914.03%-15.56
-124.65%-1.68
-154.62%-1.78
65.93%-0.23
45.87%-0.39
13.87%-0.75
10.15%-0.70
6.31%-0.69
10.05%-0.72
-62.29%-0.87
-20.56%-0.78
-31.45%-0.73
-118.00%-0.80
-27.08%-0.53
-72.05%-0.65
-125.20%-0.56
-73.93%-0.37
-54.44%-0.42
---0.38
---0.25
---0.21
---0.27
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--

FAQs

What is the income statement?

The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.
KeyAI